OTCMKTS:CHEOY Cochlear (CHEOY) Stock Forecast, Price & News $82.54 +0.05 (+0.06%) (As of 09/25/2023 ET) Add Compare Share Share Today's Range$82.19▼$82.5450-Day Range$75.90▼$88.5452-Week Range$57.62▼$89.50Volume4,761 shsAverage Volume5,339 shsMarket CapitalizationN/AP/E Ratio100.54Dividend YieldN/APrice TargetN/A ProfileProfileAnalyst RatingsChartCompetitorsDividendFinancialsHeadlinesSEC FilingsShort InterestProfileAnalyst RatingsChartCompetitorsDividendFinancialsHeadlinesSEC FilingsShort Interest About Cochlear (OTCMKTS:CHEOY) StockCochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.Read More CHEOY Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHEOY Stock News HeadlinesSeptember 15, 2023 | finance.yahoo.comDeep Dive into Cochlear Ltd's Dividend PerformanceAugust 29, 2023 | benzinga.comCochlear implants market to grow by USD 811.6 million from 2022 to 2027- TechnavioSeptember 26, 2023 | Edge On The Street (Ad)Gold Could Be Heading for Record Highs - But How to Play It?According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold. August 17, 2023 | markets.businessinsider.comJarden Remains a Hold on Cochlear Limited (CHEOF)August 15, 2023 | markets.businessinsider.comCochlear Limited (CHEOF) Receives a Hold from WilsonsAugust 15, 2023 | afr.comBlue chip Cochlear lays down blue chip result, gets more expensiveAugust 14, 2023 | fool.com.auCochlear share price lifts on 21% dividend boostAugust 14, 2023 | wsj.comCochlear Raises Dividend as Market-Share Gains Help Lift FY Underlying Profit 10%September 26, 2023 | Edge On The Street (Ad)Gold Could Be Heading for Record Highs - But How to Play It?According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold. August 11, 2023 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Cochlear Limited (OtherCHEOF) and Clinuvel Pharmaceuticals Limited (OtherCLVLF)August 3, 2023 | markets.businessinsider.comRBC Capital Sticks to Their Hold Rating for Cochlear Limited (CHEOF)August 2, 2023 | msn.comCochlear - ADR (CHEOY) Price Target Increased by 5.90% to 77.98July 21, 2023 | finance.yahoo.comCochlear Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 UpdateJune 27, 2023 | markets.businessinsider.comCochlear Limited (CHEOF) Receives a Hold from JardenJune 22, 2023 | fool.com.auCochlear share price lower on acquisition updateJune 22, 2023 | marketwatch.comCompetition and Markets Authority Prevents Cochlear-Oticon Medical MergerJune 5, 2023 | finance.yahoo.comCochlear Implants Market Size to Hit USD 3.31 Billion by 2030 at 9.10% CAGR – Report by Market Research Future (MRFR)May 11, 2023 | marketwatch.comCochlear Implant Wire Market Research & Future Success 2023-2030May 10, 2023 | marketwatch.comCochlear Implant (CI) System Market Research, 2030May 5, 2023 | marketwatch.comCochlear Implants Market Factual Overview Research Report 2023-2030May 3, 2023 | marketwatch.com2023 Cochlear Implant (CI) Market Share and Growth Rate Forecast for 2030May 2, 2023 | marketwatch.comGlobal Cochlear Implants Market [2023-2030] | Look at the Next Decade of Market GrowthMay 2, 2023 | marketwatch.comGlobal Cochlear Implant Market [2023-2030] | Uncovering Hidden Opportunities in the MarketMay 2, 2023 | marketwatch.comCompetitive Landscape Analysis of Cochlear Implant (CI) System Market (2023-2031) Top PlayersApril 27, 2023 | marketwatch.comBinaural Cochlear Implant Market Outlook by 2030April 25, 2023 | marketwatch.comCochlear Implant Systems Market Complete Overview till 2031April 21, 2023 | marketwatch.comBinaural Cochlear Implant Market 2023: Share and Growth Opportunities Forecast till 2030See More Headlines Receive CHEOY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address CHEOY Company Calendar Ex-Dividend for 10/26 Dividend9/15/2023Today9/26/2023Dividend Payable10/26/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CHEOY CUSIPN/A CIK1453930 Webwww.cochlear.com Phone(129) 428-6555FaxN/AEmployees4,800Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio100.54 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Diggory William Howitt BE (Hons) (Age 56)MBA, CEO, MD, Pres & Exec. Director Comp: $3.05MMr. Stuart SayersChief Financial OfficerMr. Jan Janssen MSc Elec Eng (Age 57)Chief Technology Officer Comp: $1.3MMs. Karen O'DriscollChief Information OfficerMs. Kristina DevonVP of Investor RelationsMs. Jennifer StevensonVP of Corp. Communications & BrandMr. Dean PhizackleaSr. VP of Global Strategic MarketingMs. Jennifer HornerySr. VP of Global People & CultureMr. Greg Bodkin BE (Hons)MComm (UNSW), Sr. VP of Global Supply ChainMr. Anthony BishopPres of Asia Pacific & Latin AmericaMore ExecutivesKey CompetitorsAmbu A/SOTCMKTS:AMBBYBICO Group AB (publ)OTCMKTS:CLLKFCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCCellaVision AB (publ)OTCMKTS:CLVSFView All Competitors CHEOY Stock - Frequently Asked Questions Should I buy or sell Cochlear stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cochlear in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" CHEOY shares. View CHEOY analyst ratings or view top-rated stocks. How have CHEOY shares performed in 2023? Cochlear's stock was trading at $68.98 at the beginning of 2023. Since then, CHEOY shares have increased by 19.7% and is now trading at $82.54. View the best growth stocks for 2023 here. Are investors shorting Cochlear? Cochlear saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 27,700 shares, an increase of 403.6% from the August 15th total of 5,500 shares. Based on an average daily volume of 20,300 shares, the short-interest ratio is presently 1.4 days. View Cochlear's Short Interest. How often does Cochlear pay dividends? What is the dividend yield for Cochlear? Cochlear announced a dividend on Wednesday, August 16th. Shareholders of record on Monday, September 18th will be given a dividend of $0.516 per share on Thursday, October 26th. The ex-dividend date is Friday, September 15th. This is a boost from the stock's previous dividend of $0.04. Read our dividend analysis for CHEOY. Is Cochlear a good dividend stock? Cochlear (OTCMKTS:CHEOY) pays an annual dividend of $1.03 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 125.46%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for CHEOY. What is Cochlear's stock symbol? Cochlear trades on the OTCMKTS under the ticker symbol "CHEOY." How do I buy shares of Cochlear? Shares of CHEOY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cochlear's stock price today? One share of CHEOY stock can currently be purchased for approximately $82.54. How many employees does Cochlear have? The company employs 4,800 workers across the globe. How can I contact Cochlear? Cochlear's mailing address is 1 University Avenue, Sydney, New South Wales 2109. The official website for the company is www.cochlear.com. The company can be reached via phone at (129) 428-6555. This page (OTCMKTS:CHEOY) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.